Literature DB >> 19780984

Clinical entity of frontotemporal dementia with motor neuron disease.

Yoshio Mitsuyama1, Teruhiko Inoue.   

Abstract

Non-Alzheimer-type dementias occur in association with a variety of pathological conditions that include a group of diseases characterized by atrophy of the frontal and temporal lobes. Frontotemporal dementia (FTD) is a clinical entity that comprises at least two distinct diseases: Pick's disease with Pick bodies and frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U). The vast majority of FTLD-U is now referred to as FTLD-TDP, following the recent discovery of TAR DNA-binding protein of 43 kDa (TDP-43) as the major constituent of the ubiquitin-positive inclusions. FTLD-TDP, but not Pick's disease with Pick bodies, is often associated with motor neuron disease (MND). MND is a group of diseases in which the central nervous system lesions were long believed to be confined to the motor neuron system. In other words, MND was not considered to be associated with other neurological symptoms such as dementia. Nevertheless, more than 200 FTD cases associated with clinical MND have been reported in Japan since 1964. Neuropathologically, MND in such FTD cases was essentially similar to MND in cases without dementia. The combination of FTD and MND was so characteristic that we considered these cases comprise a unique clinicopathological subgroup of FTD. FTD with MND and the classical MND without dementia share the occurrence of ubiquitinated TDP-43-positive inclusions, a finding that could be a key to unlock the pathological backgrounds of both diseases.

Entities:  

Mesh:

Year:  2009        PMID: 19780984     DOI: 10.1111/j.1440-1789.2009.01059.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  10 in total

Review 1.  Behavioural Variant Frontotemporal Dementia: Recent Advances in the Diagnosis and Understanding of the Disorder.

Authors:  Rebekah M Ahmed; John R Hodges; Olivier Piguet
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Medical management of frontotemporal dementias: the importance of the caregiver in symptom assessment and guidance of treatment strategies.

Authors:  Gregory A Jicha
Journal:  J Mol Neurosci       Date:  2011-06-07       Impact factor: 3.444

3.  Management of frontotemporal dementia: targeting symptom management in such a heterogeneous disease requires a wide range of therapeutic options.

Authors:  Gregory A Jicha; Peter T Nelson
Journal:  Neurodegener Dis Manag       Date:  2011-04

Review 4.  Physiological changes in neurodegeneration - mechanistic insights and clinical utility.

Authors:  Rebekah M Ahmed; Yazi D Ke; Steve Vucic; Lars M Ittner; William Seeley; John R Hodges; Olivier Piguet; Glenda Halliday; Matthew C Kiernan
Journal:  Nat Rev Neurol       Date:  2018-03-23       Impact factor: 42.937

5.  Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations.

Authors:  Julie S Snowden; Sara Rollinson; Jennifer C Thompson; Jennifer M Harris; Cheryl L Stopford; Anna M T Richardson; Matthew Jones; Alex Gerhard; Yvonne S Davidson; Andrew Robinson; Linda Gibbons; Quan Hu; Daniel DuPlessis; David Neary; David M A Mann; Stuart M Pickering-Brown
Journal:  Brain       Date:  2012-02-02       Impact factor: 13.501

6.  FUS transgenic rats develop the phenotypes of amyotrophic lateral sclerosis and frontotemporal lobar degeneration.

Authors:  Cao Huang; Hongxia Zhou; Jianbin Tong; Han Chen; Yong-Jian Liu; Dian Wang; Xiaotao Wei; Xu-Gang Xia
Journal:  PLoS Genet       Date:  2011-03-03       Impact factor: 5.917

7.  Amnesia in frontotemporal dementia with amyotrophic lateral sclerosis, masquerading Alzheimer's disease.

Authors:  A Yamanami-Irioka; T Uchihara; T Endo; T Irioka; M Watanabe; M Kitagawa; H Mizusawa
Journal:  Case Rep Neurol       Date:  2011-10-21

8.  Tackling clinical heterogeneity across the amyotrophic lateral sclerosis-frontotemporal dementia spectrum using a transdiagnostic approach.

Authors:  Rebekah M Ahmed; Martina Bocchetta; Emily G Todd; Nga Yan Tse; Emma M Devenney; Sicong Tu; Jashelle Caga; John R Hodges; Glenda M Halliday; Muireann Irish; Matthew C Kiernan; Olivier Piguet; Jonathan D Rohrer
Journal:  Brain Commun       Date:  2021-10-23

9.  Dopamine Transporter Imaging for Frontotemporal Lobar Degeneration With Motor Neuron Disease.

Authors:  Ryota Kobayashi; Shinobu Kawakatsu; Makoto Ohba; Daichi Morioka; Masafumi Kanoto; Koichi Otani
Journal:  Front Neurosci       Date:  2022-02-25       Impact factor: 4.677

Review 10.  Dementia in motor neuron disease: Reviewing the role of MRI in diagnosis.

Authors:  Antonio José da Rocha; Renato Hoffmann Nunes; Antonio Carlos Martins Maia
Journal:  Dement Neuropsychol       Date:  2015 Oct-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.